The House debated H.R. 1266, the Combating Illicit Xylazine Act, which would classify xylazine, an animal sedative increasingly found mixed with fentanyl, as a schedule III controlled substance, creating criminal penalties for illicit sale while keeping it available for veterinarians, livestock producers, and researchers. Members from both parties spoke in support, citing overdoses and injuries tied to illicit xylazine; Democrats also urged further action on prevention, treatment, and recovery funding. The bill was brought up under a motion to suspend the rules, and members encouraged a yes vote.Written by AI from the debate. Updated .
“I want the House to pass this bill to ban certain illegal uses of the drug xylazine.”
“Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1266) to prohibit certain uses of xylazine, and for other purposes, as amended. The Clerk read the title of the bill. The text of the bill is as follows:”
Official Congressional Record
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1266) to prohibit certain uses of xylazine, and for other purposes, as amended. The Clerk read the title of the bill. The text of the bill is as follows:
“I want Congress to pass this bill. It makes illegal xylazine a controlled drug so we can stop street sales, but it still lets vets and ranchers use it on animals.”
“Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1266, the Combating Illicit Xylazine Act, led by my colleagues Representatives Panetta and Pfluger. Xylazine is a veterinary drug used to sedate large animals. It has no legitimate use in humans, and it is quickly becoming one of the deadliest drugs on our streets. This bill would place xylazine in schedule III of the Controlled Substances Act while ensuring an exemption for appropriate use within the veterinary and ranching industries. The decision to place xylazine in schedule III is a product of extensive bipartisan work spanning two Congresses and two administrations, supported by both DEA and HHS. It is critical that we pass this commonsense bill to strengthen our ability to crack down on illicit xylazine distribution while preserving its legitimate veterinary and ranching uses. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.”
Official Congressional Record
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1266, the Combating Illicit Xylazine Act, led by my colleagues Representatives Panetta and Pfluger. Xylazine is a veterinary drug used to sedate large animals. It has no legitimate use in humans, and it is quickly becoming one of the deadliest drugs on our streets. This bill would place xylazine in schedule III of the Controlled Substances Act while ensuring an exemption for appropriate use within the veterinary and ranching industries. The decision to place xylazine in schedule III is a product of extensive bipartisan work spanning two Congresses and two administrations, supported by both DEA and HHS. It is critical that we pass this commonsense bill to strengthen our ability to crack down on illicit xylazine distribution while preserving its legitimate veterinary and ranching uses. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.
“Mr. Speaker, I appreciate my friend from California’s hard work on this bill and all the other colleagues he mentioned and the committee’s work. I encourage a ``yes’’ vote on this bill, and I yield back the balance of my time.”
Official Congressional Record
Mr. Speaker, I appreciate my friend from California’s hard work on this bill and all the other colleagues he mentioned and the committee’s work. I encourage a ``yes’’ vote on this bill, and I yield back the balance of my time.
